Skip to main content

. 1988 Jan 30;296(6618):307–308. doi: 10.1136/bmj.296.6618.307

Aspirin all round?

PMCID: PMC2544825 PMID: 3125876

307

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bochner F., Lloyd J. Is there an optimal dose and formulation of aspirin to prevent arterial thrombo-embolism in man? Clin Sci (Lond) 1986 Dec;71(6):625–631. doi: 10.1042/cs0710625. [DOI] [PubMed] [Google Scholar]
Czervionke R. L., Smith J. B., Fry G. L., Hoak J. C., Haycraft D. L. Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence. J Clin Invest. 1979 May;63(5):1089–1092. doi: 10.1172/JCI109379. [DOI] [PMC free article] [PubMed] [Google Scholar]
Roth G. J., Majerus P. W. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest. 1975 Sep;56(3):624–632. doi: 10.1172/JCI108132. [DOI] [PMC free article] [PubMed] [Google Scholar]
Weiss H. J., Aledort L. M. Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet. 1967 Sep 2;2(7514):495–497. doi: 10.1016/s0140-6736(67)91658-3. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES